To investigate potential therapeutic targets in CS, the focus was directed towards a frameshift mutation in PTCH1 and BCOR. It has been established that loss-of-function mutations in PTCH1 result in constitutive activation of the SHH signaling pathway35–37. Here, BCOR is linked to Cowden syndrome 1.